Primary study · included by 1 review

Association of serum lipid indices and statin consumption with periodontal status.

Sayar 2016 · Sayar F, Fallah S, Akhondi N, et al. · Oral diseases · 2016

Included by

Effect of renin-angiotensin-aldosterone system inhibitor and statin medication on periodontal status of patients at risk of cardiovascular disease: a systematic review and meta-analysis.

Non-Cochrane · intervention · 2026 · cited as Sayar F 2016 · Table 1; reference list; Figs. 3-5

Outcome this study informs	Pooled effect	Evidence	Certainty
Probing depth (mm) Systemic statin medication vs Non-statin groups (diet or normolipidemic controls) · Not specified	MD -0.38 [-0.53, -0.23]	4 studies · 232 participants	GRADE not reported
Bleeding on probing index (%) Systemic statin medication vs Non-statin groups (diet or normolipidemic controls) · Not specified	MD -13.52 [-23.20, -3.83]	3 studies · 175 participants	GRADE not reported
Clinical attachment loss (mm) Systemic statin medication vs Non-statin groups (diet or normolipidemic controls) · Not specified	MD -0.16 [-0.40, 0.07]	4 studies · 232 participants	GRADE not reported
Bleeding on probing (BOP) index, % Systemic statin medication (simvastatin, lovastatin or unspecified statin) vs Non-statin comparison (diet-controlled or normolipidemic participants) · Not specified	MD -13.52 [-23.20, -3.83]	3 studies · 175 participants	GRADE not reported

1 including review in total.